The University of Southampton
University of Southampton Institutional Repository

Cancer Variant Interpretation Group UK (CanVIG-UK): an exemplar national subspecialty multidisciplinary network

Cancer Variant Interpretation Group UK (CanVIG-UK): an exemplar national subspecialty multidisciplinary network
Cancer Variant Interpretation Group UK (CanVIG-UK): an exemplar national subspecialty multidisciplinary network
Advances in technology have led to a massive expansion in the capacity for genomic analysis, with a commensurate fall in costs. The clinical indications for genomic testing have evolved markedly; the volume of clinical sequencing has increased dramatically; and the range of clinical professionals involved in the process has broadened. There is general acceptance that our early dichotomous paradigms of variants being pathogenic–high risk and benign–no risk are overly simplistic. There is increasing recognition that the clinical interpretation of genomic data requires significant expertise in disease–gene-variant associations specific to each disease area. Inaccurate interpretation can lead to clinical mismanagement, inconsistent information within families and misdirection of resources. It is for this reason that ‘national subspecialist multidisciplinary meetings’ (MDMs) for genomic interpretation have been articulated as key for the new NHS Genomic Medicine Service, of which Cancer Variant Interpretation Group UK (CanVIG-UK) is an early exemplar. CanVIG-UK was established in 2017 and now has >100 UK members, including at least one clinical diagnostic scientist and one clinical cancer geneticist from each of the 25 regional molecular genetics laboratories of the UK and Ireland. Through CanVIG-UK, we have established national consensus around variant interpretation for cancer susceptibility genes via monthly national teleconferenced MDMs and collaborative data sharing using a secure online portal. We describe here the activities of CanVIG-UK, including exemplar outputs and feedback from the membership.
clinical genetics, genetics, guidelines, molecular genetics, oncology
0022-2593
829-834
Garrett, Alice
d8fcdea3-8231-4d5e-8ada-4f932ca1a0c3
Callaway, Alison
07ee9b43-9249-4a56-9582-4dc41d613101
Durkie, Miranda
7caca497-e12f-4f13-99e0-f40e767f0163
Cubuk, Cankut
9a916072-4100-4c45-ab8e-8a67cf6e2170
Alikian, Mary
0bfe21c3-dd22-4605-b457-65bb24d9fa94
Burghel, George J
9f2ea756-eaac-42a6-a059-68de98809d5e
Robinson, Rachel
b81f9f32-b468-451d-959b-355aa680f7fb
Izatt, Louise
5d6201a8-8a56-4923-ac9d-75dca6be0a40
Talukdar, Sabrina
a04a95d0-9f03-45bd-a615-b654875df5b5
Side, Lucy
197fd9f8-2bd8-4e7e-b46f-4a87df3f20d2
Cranston, Treena
4970ab26-797b-4818-ab1f-dfcd339ce96f
Palmer-smith, Sheila
c1224d8f-13f0-4f41-898d-a110f7088f7e
Baralle, Diana
faac16e5-7928-4801-9811-8b3a9ea4bb91
Berry, Ian R.
b720cb74-2247-4906-8c4e-9bde4742b772
Drummond, James
15dae66f-25bc-4d38-8a4d-7f0368c384e9
Wallace, Andrew J
31501286-9c2e-4c8e-9985-cc2244c26249
Norbury, Gail
261bf184-6cd8-470c-ae6a-011a85a3f20f
Eccles, Diana M.
5b59bc73-11c9-4cf0-a9d5-7a8e523eee23
Ellard, Sian
6c9b0ede-8980-4602-b063-444b165baa09
Lalloo, Fiona
d7ac29ee-10db-49a5-af3c-265b6d1c113d
Evans, D Gareth
81221452-69a9-453c-ab09-568665af0187
Woodward, Emma
3195eb52-fd0d-4ae6-af64-a6530de11de6
Tischkowitz, Marc
1e7750c2-91a5-4079-a1f0-f59a1f42405b
Hanson, Helen
fe4a8065-8b0d-4b30-a658-cd433570c2ec
Turnbull, Clare
63408861-754b-4f55-a010-29d1bea914e2
Garrett, Alice
d8fcdea3-8231-4d5e-8ada-4f932ca1a0c3
Callaway, Alison
07ee9b43-9249-4a56-9582-4dc41d613101
Durkie, Miranda
7caca497-e12f-4f13-99e0-f40e767f0163
Cubuk, Cankut
9a916072-4100-4c45-ab8e-8a67cf6e2170
Alikian, Mary
0bfe21c3-dd22-4605-b457-65bb24d9fa94
Burghel, George J
9f2ea756-eaac-42a6-a059-68de98809d5e
Robinson, Rachel
b81f9f32-b468-451d-959b-355aa680f7fb
Izatt, Louise
5d6201a8-8a56-4923-ac9d-75dca6be0a40
Talukdar, Sabrina
a04a95d0-9f03-45bd-a615-b654875df5b5
Side, Lucy
197fd9f8-2bd8-4e7e-b46f-4a87df3f20d2
Cranston, Treena
4970ab26-797b-4818-ab1f-dfcd339ce96f
Palmer-smith, Sheila
c1224d8f-13f0-4f41-898d-a110f7088f7e
Baralle, Diana
faac16e5-7928-4801-9811-8b3a9ea4bb91
Berry, Ian R.
b720cb74-2247-4906-8c4e-9bde4742b772
Drummond, James
15dae66f-25bc-4d38-8a4d-7f0368c384e9
Wallace, Andrew J
31501286-9c2e-4c8e-9985-cc2244c26249
Norbury, Gail
261bf184-6cd8-470c-ae6a-011a85a3f20f
Eccles, Diana M.
5b59bc73-11c9-4cf0-a9d5-7a8e523eee23
Ellard, Sian
6c9b0ede-8980-4602-b063-444b165baa09
Lalloo, Fiona
d7ac29ee-10db-49a5-af3c-265b6d1c113d
Evans, D Gareth
81221452-69a9-453c-ab09-568665af0187
Woodward, Emma
3195eb52-fd0d-4ae6-af64-a6530de11de6
Tischkowitz, Marc
1e7750c2-91a5-4079-a1f0-f59a1f42405b
Hanson, Helen
fe4a8065-8b0d-4b30-a658-cd433570c2ec
Turnbull, Clare
63408861-754b-4f55-a010-29d1bea914e2

Garrett, Alice, Callaway, Alison, Durkie, Miranda, Cubuk, Cankut, Alikian, Mary, Burghel, George J, Robinson, Rachel, Izatt, Louise, Talukdar, Sabrina, Side, Lucy, Cranston, Treena, Palmer-smith, Sheila, Baralle, Diana, Berry, Ian R., Drummond, James, Wallace, Andrew J, Norbury, Gail, Eccles, Diana M., Ellard, Sian, Lalloo, Fiona, Evans, D Gareth, Woodward, Emma, Tischkowitz, Marc, Hanson, Helen and Turnbull, Clare (2020) Cancer Variant Interpretation Group UK (CanVIG-UK): an exemplar national subspecialty multidisciplinary network. Journal of Medical Genetics, 57 (12), 829-834. (doi:10.1136/jmedgenet-2019-106759).

Record type: Article

Abstract

Advances in technology have led to a massive expansion in the capacity for genomic analysis, with a commensurate fall in costs. The clinical indications for genomic testing have evolved markedly; the volume of clinical sequencing has increased dramatically; and the range of clinical professionals involved in the process has broadened. There is general acceptance that our early dichotomous paradigms of variants being pathogenic–high risk and benign–no risk are overly simplistic. There is increasing recognition that the clinical interpretation of genomic data requires significant expertise in disease–gene-variant associations specific to each disease area. Inaccurate interpretation can lead to clinical mismanagement, inconsistent information within families and misdirection of resources. It is for this reason that ‘national subspecialist multidisciplinary meetings’ (MDMs) for genomic interpretation have been articulated as key for the new NHS Genomic Medicine Service, of which Cancer Variant Interpretation Group UK (CanVIG-UK) is an early exemplar. CanVIG-UK was established in 2017 and now has >100 UK members, including at least one clinical diagnostic scientist and one clinical cancer geneticist from each of the 25 regional molecular genetics laboratories of the UK and Ireland. Through CanVIG-UK, we have established national consensus around variant interpretation for cancer susceptibility genes via monthly national teleconferenced MDMs and collaborative data sharing using a secure online portal. We describe here the activities of CanVIG-UK, including exemplar outputs and feedback from the membership.

Text
jmedgenet-2019-106759.full - Accepted Manuscript
Available under License Creative Commons Attribution.
Download (797kB)
Text
jmedgenet-2019-106759.full - Version of Record
Available under License Creative Commons Attribution.
Download (797kB)

More information

Accepted/In Press date: 7 February 2020
e-pub ahead of print date: 13 March 2020
Published date: 1 December 2020
Additional Information: Funding Information: Maintenance of a national multidisciplinary network, coordination of a regular teleconferenced MDMs and development of a data system is only feasible via sustained support. The activities of CanVIG-UK are currently supported by a Cancer Research UK Catalyst Award (CanGene-CanVar, @CangeneCanvar, C61296/A27223). Funding Information: Funding this work is supported by the CRUK Catalyst award CanGene-CanVar (C61296/a27223). eRW and DGe are supported by the manchester national institute for Health Research Biomedical Research Centre (is-BRC-1215-20007). Publisher Copyright: © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY. Published by BMJ.
Keywords: clinical genetics, genetics, guidelines, molecular genetics, oncology

Identifiers

Local EPrints ID: 438845
URI: http://eprints.soton.ac.uk/id/eprint/438845
ISSN: 0022-2593
PURE UUID: 7d539cc0-bef4-49ea-a92d-2bfd900a21e2
ORCID for Diana Baralle: ORCID iD orcid.org/0000-0003-3217-4833
ORCID for Diana M. Eccles: ORCID iD orcid.org/0000-0002-9935-3169

Catalogue record

Date deposited: 25 Mar 2020 17:31
Last modified: 17 Mar 2024 03:13

Export record

Altmetrics

Contributors

Author: Alice Garrett
Author: Alison Callaway
Author: Miranda Durkie
Author: Cankut Cubuk
Author: Mary Alikian
Author: George J Burghel
Author: Rachel Robinson
Author: Louise Izatt
Author: Sabrina Talukdar
Author: Lucy Side
Author: Treena Cranston
Author: Sheila Palmer-smith
Author: Diana Baralle ORCID iD
Author: Ian R. Berry
Author: James Drummond
Author: Andrew J Wallace
Author: Gail Norbury
Author: Diana M. Eccles ORCID iD
Author: Sian Ellard
Author: Fiona Lalloo
Author: D Gareth Evans
Author: Emma Woodward
Author: Marc Tischkowitz
Author: Helen Hanson
Author: Clare Turnbull

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×